- Home
- WST vs FCNCA Comparison
WST vs FCNCA Comparison
Compare WST & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- FCNCA
- Stock Information
- Founded
- WST 1923
- FCNCA 1898
- Country
- WST United States
- FCNCA United States
- Employees
- WST N/A
- FCNCA N/A
- Industry
- WST Medical/Dental Instruments
- FCNCA Major Banks
- Sector
- WST Health Care
- FCNCA Finance
- Exchange
- WST Nasdaq
- FCNCA Nasdaq
- Market Cap
- WST 15.6B
- FCNCA 25.4B
- IPO Year
- WST N/A
- FCNCA N/A
- Fundamental
- Price
- WST $216.71
- FCNCA $1,959.03
- Analyst Decision
- WST Buy
- FCNCA Buy
- Analyst Count
- WST 7
- FCNCA 9
- Target Price
- WST $331.67
- FCNCA $2,420.44
- AVG Volume (30 Days)
- WST 690.0K
- FCNCA 81.1K
- Earning Date
- WST 07-24-2025
- FCNCA 07-24-2025
- Dividend Yield
- WST 0.38%
- FCNCA 0.40%
- EPS Growth
- WST N/A
- FCNCA N/A
- EPS
- WST 6.37
- FCNCA 175.01
- Revenue
- WST $2,895,800,000.00
- FCNCA $9,091,000,000.00
- Revenue This Year
- WST $3.38
- FCNCA N/A
- Revenue Next Year
- WST $5.85
- FCNCA $2.54
- P/E Ratio
- WST $34.31
- FCNCA $11.24
- Revenue Growth
- WST N/A
- FCNCA N/A
- 52 Week Low
- WST $187.43
- FCNCA $1,473.62
- 52 Week High
- WST $352.33
- FCNCA $2,412.93
- Technical
- Relative Strength Index (RSI)
- WST 48.20
- FCNCA 65.88
- Support Level
- WST $215.67
- FCNCA $1,897.33
- Resistance Level
- WST $223.77
- FCNCA $1,946.00
- Average True Range (ATR)
- WST 4.99
- FCNCA 36.74
- MACD
- WST -0.52
- FCNCA 11.27
- Stochastic Oscillator
- WST 19.10
- FCNCA 98.71
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About FCNCA First Citizens BancShares Inc.
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.